Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Significant Results

<< Previous

Bullboard Posts

Next >>

Comment by Yakpion Aug 21, 2021 7:28pm

237 Views

Post# 33745508

RE:Significant Results

Agreed biggdogg this is a MAJOR milestone. And done very professionally. In today's world of resource scarcity and securing supplies it is all aligning up perfectly. Disclosurer I am a long term shareholder over 5 years. One day the stock will sky rocket and everyone will be wondering about this "overnight" success!

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3